Nasdaq
JANX
Janux Therapeutics, Inc.
- Health Care
- Listed 2021
- 1 day
- +0.6%
- 1 month
- −0.3%
- 1 year
- −33.4%
$16.10 · Mkt cap $982M
At the 6 Aug 2026 close
Nasdaq
Janux Therapeutics, Inc.
$16.10 · Mkt cap $982M
At the 6 Aug 2026 close
Janux Therapeutics, Inc. trades under the ticker JANX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $982M. The last closing price was $16.10, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −33.4%, and −0.3% over the past month. Returns are price returns and exclude dividends.
This page exists because JANX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.